Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cytokine Release Syndrome × siltuximab × Clear all

Phase

Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Smoldering Multiple Myeloma 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasms, Plasma Cell 1 Monoclonal Gammopathy of Undetermined Significance 1 Leukemia, Myeloid, Acute 1 Cytokine Release Syndrome 1 Castleman Disease 1

Interventions

fludarabine 2 Cyclophosphamide 2 siltuximab 1 fludarabine phosphate 1 Leukapheresis 1 Bendamustine Hydrochloride 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06447376 2025-05-11

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

Case Comprehensive Cancer Center

Phase 1 Recruiting

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡